药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dezocine
Pertuzumab
The risk or severity of cardiotoxicity can be increased when Pertuzumab is combined with Cabazitaxel.
Dezocine
Paclitaxel poliglumex
The risk or severity of cardiotoxicity can be increased when Cabazitaxel is combined with Paclitaxel poliglumex.
Dezocine
Paclitaxel trevatide
The risk or severity of cardiotoxicity can be increased when Paclitaxel trevatide is combined with Cabazitaxel.
Dezocine
Aldoxorubicin
The risk or severity of cardiotoxicity can be increased when Aldoxorubicin is combined with Cabazitaxel.
Dezocine
Nedaplatin
The risk or severity of adverse effects can be increased when Nedaplatin is combined with Cabazitaxel.
Dezocine
Platinum
The risk or severity of adverse effects can be increased when Platinum is combined with Cabazitaxel.
Dezocine
Satraplatin
The risk or severity of adverse effects can be increased when Satraplatin is combined with Cabazitaxel.
Dezocine
Acetyldigoxin
Acetyldigoxin may decrease the cardiotoxic activities of Cabazitaxel.
Dezocine
Metildigoxin
Metildigoxin may decrease the cardiotoxic activities of Cabazitaxel.
Dezocine
Peruvoside
Peruvoside may decrease the cardiotoxic activities of Cabazitaxel.
Dezocine
Gitoformate
Gitoformate may decrease the cardiotoxic activities of Cabazitaxel.
Dezocine
Lanatoside C
Lanatoside C may decrease the cardiotoxic activities of Cabazitaxel.
Dezocine
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Cabazitaxel.
Dezocine
Cymarin
Cymarin may decrease the cardiotoxic activities of Cabazitaxel.
Dezocine
Oleandrin
Oleandrin may decrease the cardiotoxic activities of Cabazitaxel.
Dezocine
Lumacaftor
The serum concentration of Cabazitaxel can be decreased when it is combined with Lumacaftor.
Dezocine
Fingolimod
Cabazitaxel may increase the immunosuppressive activities of Fingolimod.
Dezocine
Eluxadoline
The serum concentration of Eluxadoline can be increased when it is combined with Cabazitaxel.
Dezocine
Tofacitinib
Cabazitaxel may increase the immunosuppressive activities of Tofacitinib.
Dezocine
Crizotinib
The metabolism of Crizotinib can be decreased when combined with Cabazitaxel.